TRDX Daily US Market Briefing MIXED / ROTATIONAL
Updated 8:45 AM ET
Futures Chart Technical Analysis
Next-candle bias: NEUTRAL — today’s overnight range is unusually tight (7,748.00–7,770.75, roughly 23 handles) and the index is being pulled in two directions: a defensive/value bid keeping YM at record highs against a genuine software and chip de-rating dragging NQ. This is a coiled, indecisive candle ahead of tomorrow’s payrolls print; treat the ES as the referee, not the leader, until 7,770.75 or 7,748.00 breaks on volume.
Support: 7,748.00 (overnight low) → 7,628.75 (Wick Sweep) → 7,530.25 (secondary Wick Sweep / Long Lifeline)
Resistance: 7,770.75 (overnight high) → 7,820.25 (range high / Premium boundary)
Next-candle bias: BEARISH — the only one of the four contracts that is red, and the loss of the 29,577.50 Wick Sweep it reclaimed just two sessions ago is a genuine structural failure, not noise. The driver is not macro: it is a broad software multiple compression (DDOG, HUBS, APP, FIG, EPAM all down double digits pre-market) layered on top of a chip complex that swooned again overnight in Asia (SK Hynix, KOSPI −4%). Below 29,364.75 the 29,000 handle comes into play quickly.
Support: 29,364.75 (overnight low) → 29,000 psychological → 28,750 (CHoCH)
Resistance: 29,577.50 (Wick Sweep / Long Lifeline, now resistance) → 29,679.50 (overnight high) → 30,000 Premium boundary
Next-candle bias: BULLISH — a defensive/value rotation is doing the work here. Money leaving software and semis is landing in industrials, energy (oil bouncing +1.3%), materials (gold miners +7.4% Wednesday) and healthcare (INSM +26%). As long as the Nasdaq’s weakness stays a sector story rather than a systemic one, YM continues to absorb the rotation. Holding 54,544 keeps the record-high retest live.
Support: 54,544 (overnight low) → 54,000 (breakout shelf) → 52,804 (former Wick Sweep)
Resistance: 54,678 (overnight high) → 54,884 (all-time high)
Next-candle bias: NEUTRAL — small caps are refusing to confirm either side. They are not participating in the Dow’s record push, but they are also not breaking with the Nasdaq, which is a mild positive for breadth. With a softening dollar (DXY 99.74, well below its 101.8 high) and tomorrow’s payrolls print as the gate, RTY is likely to stay range-bound until the labor data resolves.
Support: 3,021.1 (overnight low) → 3,016.3 (Wick Sweep) → 2,960 / 2,920 (CHoCH zone)
Resistance: 3,032.7 (overnight high) → 3,046 (Tuesday high) → 3,068.4 (range high)
Sector Heatmap
Breadth: Technology is the session’s clear laggard as the software complex de-rates in unison (DDOG −18.1%, HUBS −23.8%, APP −18.8%, FIG −14.8%, EPAM −15.9%) on top of an overnight chip swoon in Asia. Materials leads on the gold squeeze — GDX and GDXJ both gained 7.4% Wednesday as bullion posted its best day in six months. Energy rebounds as WTI and Brent bounce ~1.2% off a three-session slide, with the Hormuz deal still unconfirmed. Consumer Staples is dragged by CELH’s −14.4% revenue-miss gap, and Financials by FISV’s −12.4%. Healthcare is the session’s quiet second-place sector, carrying three separate catalysts: INSM’s +28.7% guidance-raise gap, MRNA’s FDA approval of the first mRNA seasonal flu vaccine, and NVO bouncing after a guidance raise was initially sold. Note that Technology’s decline is being cushioned from within — NVDA is up on the SpaceX exclusive-supply win even as the software cohort de-rates. ~est. from pre-market ETF proxies and scanner sector tags.
Market Bias
- 🔴 Software beats are being punished, not rewarded: DDOG −18.1% (36% rev growth, billings +38.1%, raised FY EPS guide), HUBS −23.8% (EPS beat, FY revenue outlook cut), APP −18.8% (0.8% rev miss on +53% growth), FIG −14.8% (beat-and-raise), EPAM −15.9%
- 🟢 Nvidia wins SpaceX’s AI stack outright: Musk named NVDA the exclusive AI-chip supplier for the new “Starmind” orbital-compute network — Rubin GPUs and Vera CPUs running data-centre-grade processing in space. NVDA added roughly $178B of market value; AMD lost its place in the stack and fell 7.0% despite record results.
- 🟡 SpaceX’s ~$116B, 911.5M-share lockup expires today — but it is the first tranche of a deliberately staggered schedule, only the first 20% of eligible shares can move today, and Musk plus select insiders stay locked until mid-2027. The stock already absorbed a −13.6% day on 208.5M shares and is bid +2.25% pre-market.
- 🔴 Asia sold the US tech pullback hard: KOSPI −4%, Nikkei −1%; SK Hynix swooned for the second time in little over a week
- 🟢 Dow futures hold within 271 points of an all-time high (54,884) on a clean defensive/value rotation — the money leaving software is landing, not exiting
- 🟢 Gold’s best day in six months: GLD +4.1% on 2.1× normal volume to a seven-week high, SLV +4.1%, GDX/GDXJ +7.4% — broad confirmation from metals, miners, bonds and the dollar
- 🟢 Gaps and volume expanding together on the leaders: between the two scanner pulls U went from +12.83% on 2.10M shares to +16.97% on 2.50M, IONQ from +3.81%/1.55M to +4.98%/1.72M, INSM from +26.28%/243K to +28.70%/344K, and OKLO’s pre-market volume tripled from 192K to 618K. Accumulation, not fading gaps.
- 🟢 A three-name healthcare catalyst cluster: INSM +28.7% (FY BRINSUPRI guide raised to $1.25–1.40B from ≥$1B), MRNA on FDA approval of mFLUSIVA — the first mRNA-based seasonal flu vaccine — and NVO bouncing after its raised guidance was initially sold
- 🟡 July labor data is running two ways: Challenger job cuts fell to 33,429, the fewest in two years (−27% MoM, −46% YoY), and ADP private payrolls came in below forecast — but weekly claims have been near 57-year lows
- 🟡 Fed is split and leaning hawkish: Governor Cook said she is prepared to raise rates if inflation doesn’t come down; SF’s Daly is comfortable with the current 3.50–3.75% stance. This is not a rate-cut tape.
- 🟡 Hormuz deal still unconfirmed: Iran and Oman agreed coordinates for a shipping route Wednesday, but Bloomberg reports the agreement “remained elusive” overnight — crude is bouncing +1.2% after a three-session −11.1% slide
- 🟡 Leverage warnings stacking up: Jamie Dimon says market leverage remains “pretty high”; JPMorgan warns July’s hedge-fund torching may leave tech at the mercy of retail flows
- 🟢 VIX still only 16.00 (+1.27%) — low enough to argue this is rotation rather than genuine de-risking
Sources: Reuters Morning Bid, Bloomberg Morning Briefing Americas, Stocktwits Daily Rip, CNBC, Barron’s, Benzinga, Yahoo Finance, CNN Fear & Greed Index, TradingView ES1!/NQ1!/YM1!/RTY1!/VIX/DXY/US10Y/MCL1!/BRN1! charts, pre-market scanner data (Aug 6 2026)
Overall Economic Summary
The market has split cleanly down the middle. The Dow closed at a record Wednesday, up more than 260 points, and Dow futures are still bid this morning — while the Nasdaq pulled back and Nasdaq futures are the only red contract on the board. The cause is not macro. It is a synchronized de-rating of enterprise software, and the striking part is that almost every one of these companies beat. Datadog delivered 36% year-over-year revenue growth, $1.18B in billings (+38.1%), 4,720 customers paying more than $100,000 annually, and raised its full-year adjusted EPS guidance to $2.52 at the midpoint — and the stock fell more than 17%, having nearly doubled in 2026 (+99.9%) going into the print. HubSpot posted adjusted EPS of $3.26 against a $3.02 consensus and revenue of $911.7M (+19.8% YoY), then cut its full-year revenue outlook and guided Q3 to roughly $924.5M, about 1.8% below estimates, while adding only 7,000 net-new customers versus an internal target of 9,000–10,000 — shares fell ~20% after hours and are indicated −23.8% pre-market. AppLovin grew revenue 53% year-over-year and net income 55% to $1.267B, missed the top line by 0.8%, guided softly, and shed roughly $40.2B of equity value at the session low. Figma beat and raised — revenue $370.08M versus $351.56M estimated, adjusted EPS $0.08 versus $0.04 — and still fell double digits as investors looked past growth toward approaching lockup releases. EPAM is down 15.9%. The multiple, not the fundamentals, is what is being repriced.
Sitting on top of that is the single largest supply event of the year: SpaceX’s first share lockup expires today, releasing approximately 911.5 million shares worth roughly $116 billion. Insiders may sell up to the first 20% of eligible shares, with a further 455.8 million potentially available under certain conditions; shares held by Elon Musk and a select group of insiders remain locked until mid-2027, and the schedule is deliberately staggered across multiple dates rather than a single cliff. It lands one session after SpaceX’s first-ever public earnings report, which showed adjusted EPS of −$0.09 on $7.81B of revenue (+92% YoY, beating the $6.93B estimate) but quarterly capital expenditure of $18.37B — 39% above the $13.22B analyst estimate, with $15.8B of it on AI infrastructure versus $749M a year earlier. Musk used the call to name Nvidia the exclusive AI-chip supplier, which sent NVDA up 3.4% and left AMD down 7.0% despite record results (adjusted EPS $1.66 vs. $1.62 est., revenue +50% to $11.54B, Data Center +107% to $6.7B). SPCX fell 13.6% Wednesday on 208.5 million shares and remains below its $135 IPO price and roughly 52% below the $225.64 intraday record set June 16. It is indicated +2.25% pre-market on 10.97 million shares — by far the heaviest pre-market volume on the entire scanner, and a bid rather than a slide into the unlock. The other side of that same call is Nvidia: the exclusive-supply win added roughly $178 billion to NVDA’s market value and underpins the new "Starmind" programme, an orbital network of compute satellites housing Rubin GPUs and Vera CPUs to run data-centre-grade processing directly in space.
The rotation destination is visible in the commodity and metals complex. Gold posted its best day in about six months Wednesday and hit a seven-week high, with GLD +4.1% on 2.1× normal volume, SLV +4.1%, and GDX and GDXJ both +7.4% — a move confirmed simultaneously by metals, miners, bonds and a softening dollar rather than a single-chart breakout. Bullion is still down roughly 20% from where it stood when the Iran war began in late February. Crude went the other way: Iran and Oman agreed Wednesday on coordinates for a Strait of Hormuz shipping route and began finalizing a joint announcement, a framework that would hand Tehran control over ships entering the Gulf — one of the biggest concessions yet, and one Washington has not clearly accepted. XLE fell 2.1% and USO has now lost 11.1% across three sessions. This morning both benchmarks are bouncing, with WTI +1.29% to $76.19 and Brent +1.18% to $80.39, after Bloomberg reported overnight that the deal “remained elusive.”
Macro is the wildcard into tomorrow. Today brings weekly jobless claims at 8:30 AM ET (consensus 203K versus 197K prior), alongside preliminary Q2 nonfarm productivity (consensus +0.6–0.7% vs. +0.3%) and unit labor costs (consensus +2.2% vs. +1.8%) — the labor-cost print is the one with genuine inflation signal. Challenger job cuts for July came in at 33,429, the fewest in two years, down 27% month-over-month and 46% year-over-year, with AI leading all stated reasons for a fifth straight month. ADP private payrolls for July landed below forecast. But weekly claims have recently run near 57-year lows, and the Fed is openly split: Governor Lisa Cook said overnight she is prepared to raise rates if inflation doesn’t come down soon, while San Francisco’s Mary Daly signalled comfort with the current 3.50–3.75% stance. The 10-year sits at 4.645% (+0.65%), off the 4.745% range high, and the dollar is soft at 99.739, well below its 101.80 peak, with a BOS to the downside on the daily. Friday’s July nonfarm payrolls report is the week’s decisive print — and with a hawkish governor on the record, a hot number is the tail risk this tape is not positioned for.
Market Sentiment
YM1! leads at +0.22% within 271 points of a record, ES1! is effectively flat at +0.12% inside a 23-handle overnight range, RTY1! is dead flat at +0.01%, and NQ1! is the lone decliner at −0.57% after slicing back through the 29,577.50 Wick Sweep it reclaimed only two sessions ago. That is the shape of a rotation, not a risk-off day — and VIX at 16.00 confirms it. Per today’s direction the Top 5 is built entirely long, and the second scanner pull supports it: every one of these names saw its gap and its pre-market volume expand between the 07:00 and 09:00 reads, which is the accumulation signature rather than a fading pre-market pop. U is the standout at +16.97% on 2.50M shares with a 5.99× 5-minute RVOL — the largest qualifying gap on the board and relative strength inside the one cohort being punished today. NVDA is the cleanest structural story: Musk named it SpaceX’s exclusive AI-chip supplier for the “Starmind” orbital-compute network, worth roughly $178B in added market value, and it is being confirmed independently by TSMC’s +30% monthly sales and Foxconn’s record July revenue (+54.2% YoY). SPCX flips to the long side on the read that the lockup is a telegraphed, staggered, partially-capped event that the stock already paid for with a −13.6% day on 208.5M shares — buy-the-news off a level still below the $135 IPO price. IONQ brings the widest range on the board (β4.99, ATR $3.28) on a record +287% revenue quarter and a raised full-year guide, and OKLO carries the highest 5-minute RVOL anywhere on the scanner at 9.25× with pre-market volume now tripled to 618K. Caveats: an all-long Top 5 means correlation risk is real — if NQ1! loses 29,364.75 these names go down together, so stagger entries rather than opening the full book at 9:30. SPCX is the highest-variance name here: the long thesis depends on actual insider selling coming in lighter than feared, and if genuine size prints the −13.6% day extends rather than reverses. OKLO reports tomorrow morning alongside payrolls — that is a same-day trade only. And the software short side is crowded: four of the five biggest decliners actually beat, which makes ORCL a defined-stop short rather than a conviction hold.
Key Market Stats
Economic Calendar
| Time (ET) | Event | Consensus | Prior | Impact |
|---|---|---|---|---|
| 7:30 AM | Challenger Job Cuts (Jul) | — | 33,429 announced (−27% MoM, −46% YoY) | LOW |
| 8:30 AM | 🟡 Initial Jobless Claims (wk ended Aug 1) | 203K | 197K | HIGH |
| 8:30 AM | Continuing Jobless Claims | 1,790K | 1,782K | MED |
| 8:30 AM | 🟡 Unit Labor Costs (Q2 preliminary) | +2.2% | +1.8% | HIGH |
| 8:30 AM | Nonfarm Productivity (Q2 preliminary) | +0.6% to +0.7% | +0.3% | MED |
| All Session | 🔴 SpaceX (SPCX) Lockup Expiry — 911.5M shares / ~$116B | — | — | HIGH |
| — | Trump Schedule — returns from Las Vegas to the White House, time TBD. No confirmed remarks, meetings, press conference or interview inside the 9:30 AM–4:00 PM ET window. | — | — | LOW |
⚡ The 8:30 AM block is the day’s only scheduled macro risk, and unit labor costs are the print with real inflation signal — a hot number feeds directly into Governor Cook’s stated willingness to hike. Everything else defers to tomorrow’s July nonfarm payrolls.
Today’s Earnings
Guiding to adjusted and organic revenue growth of just 1–3% with adjusted EPS of $8.00–$8.30. The stock had already slipped 3.0% Wednesday, and Forbes argued this week that Fiserv’s real problem may be governance rather than payments. Excluded from the Top 5 on the Beta ≥1.0 floor (β0.85) despite the 12%+ gap.
MRNA: the FDA approved mFLUSIVA (mRNA-1010) on Aug. 5 for adults 50+ — the first mRNA-based seasonal influenza vaccine and Moderna’s fourth approved US product; Q2 revenue $145M (+2%) came in above the top end of guidance. NVO: Q2 adjusted sales +7% to DKK 78.49B with FY26 guidance raised on rapid Wegovy-pill uptake, but shares fell 4–6% on pipeline setbacks and Lilly competition — today’s move is the bounce off that reaction.
INSM: revenue $425.5M vs. $393.4M est., loss $0.06 vs. $0.68 est., FY BRINSUPRI guide raised to $1.25–1.40B from ≥$1B. U: Q2 print with consensus EPS ~$0.24 (+192% YoY) on ~$510.9M revenue. IONQ: record $80.1M revenue (+287% YoY), FY guide raised to $280–290M, RPOs $485M vs. $122M.
DDOG beat and raised FY EPS → −18.1%. HUBS beat EPS but cut the FY revenue outlook → −23.8%. APP grew revenue 53% and missed by 0.8% → −18.8%. FIG beat and raised → −14.8%. CELH is the one clean miss: $817.9M revenue vs. $870M est., adjusted EPS $0.36 vs. $0.39, flagship brand −11.7% → −14.4%.
⚡ Also today: Warner Bros. Discovery and ConocoPhillips report BMO; Airbnb, Lyft and Cloudflare report AMC. Oklo (OKLO) reports Q2 tomorrow, Aug. 7 — the same morning as July nonfarm payrolls.
Key Events Today
🔓 SpaceX’s ~$116B Lockup Expires Today — and the Stock Is Bid
The bearish case is well known and well telegraphed, which is exactly why the setup is interesting: only the first 20% of eligible shares can move today, a further 455.8M is conditional, Musk and a select group stay locked until mid-2027, and the schedule is deliberately staggered across multiple dates rather than a single cliff. The stock already paid for it with a −13.6% day on 208.5M shares. It carries 10.97M pre-market shares — roughly 4× the next-heaviest name — and is up 2.25%.
💸 The Software “Beat-and-Punish” Repricing
Datadog raised FY guidance and fell 17%+. Figma beat and raised and fell double digits. AppLovin grew revenue 53% and lost ~$40B of equity value on a 0.8% miss. HubSpot beat EPS but cut the FY revenue outlook and added only 7,000 net-new customers versus a 9,000–10,000 internal target. This is multiple compression across a whole cohort, which is why it is showing up in NQ1! rather than in any single chart.
🕊️ Hormuz Deal Agreed on Paper, Elusive in Practice
Iran and Oman agreed Wednesday on coordinates for a shipping route and began finalizing a joint announcement. The framework would give Tehran control over ships entering the Gulf — one of the biggest concessions yet, per Reuters — and it is not clear Washington accepts it. Bloomberg reported overnight that the deal “remained elusive.” Roughly one-fifth of globally traded oil and gas has historically passed through the strait.
🛰️ Nvidia Wins SpaceX’s AI Stack Outright
Musk said SpaceX will build its AI infrastructure exclusively on Nvidia chips going forward, powering the new “Starmind” project — an orbital network of compute satellites housing Nvidia Rubin GPUs and Vera CPUs to run data-centre-grade processing directly in space. NVDA gained roughly $178B in market value and rose 3.4% Wednesday while the broad chip tape sold off; AMD lost its place in the stack and fell 7.0% despite record results.
🥇 Gold’s Best Day in Six Months
GLD +4.1% to $389.64 on 2.1× normal volume, SLV +4.1%, GDX and GDXJ both +7.4%, with the 10-year slipping to 4.61% and the dollar softening. Bullion hit a seven-week high but remains ~20% below where it stood when the Iran war began in late February. Today’s claims print is the next test — a yield rebound could challenge the momentum quickly. Watch whether GLD holds the $384 area.
Top 5 Movers
All five long today per desk direction. Figures reflect the second scanner pull (07:00–09:00 ET), in which every leader’s gap and pre-market volume expanded versus the first read — the accumulation signature rather than a fading pre-market pop.
Research Themes
🔴 Beats Are No Longer Clearing the Bar
Four of the five biggest software decliners this morning beat their quarter. Datadog raised full-year EPS guidance and fell 16–18%. Figma beat and raised and fell 15.2%. AppLovin grew revenue 53% and lost roughly $40B of equity value on a 0.8% top-line miss. Only HubSpot cut guidance outright. What is being repriced is the multiple, and the trigger is positioning: Datadog had nearly doubled in 2026 (+99.9%) going into the print, and JPMorgan warns that July’s hedge-fund torching may have left tech at the mercy of retail flows. Note the second scanner pull shows several of these names improving off their worst levels — DDOG from −18.07% to −15.95% — which is the squeeze risk in action.
🟢 Gold Squeeze vs. Energy Unwind
Gold posted its best day in about six months Wednesday and hit a seven-week high — GLD +4.1% to $389.64 on 2.1× normal volume, SLV +4.1%, GDX and GDXJ both +7.4% — while energy went the other way, with XLE −2.1% and USO now −11.1% across three sessions on Hormuz-deal progress. Both crude benchmarks are bouncing this morning (WTI +1.29%, Brent +1.18%) after Bloomberg reported the Iran–Oman agreement “remained elusive” overnight. The move was confirmed simultaneously by metals, miners, bonds and a softening dollar, which makes it broader than a one-chart breakout.
Secondary Movers
| Ticker | Company | Price | PM Gap % | PM Vol | Beta / ATR | Note |
|---|---|---|---|---|---|---|
| INSM | Insmed Incorporated | $99.02 | +28.70% | 344K | β0.33 / ATR $3.82 | The strongest fundamental catalyst on the entire board, and it strengthened on the second pull — gap from +26.28% to +28.70%, volume from 243K to 344K. Q2 revenue $425.5M vs. $393.4M est.; loss of $0.06/sh vs. a $0.68 estimated loss. BRINSUPRI generated $309.2M, up 49% quarter-over-quarter, and full-year BRINSUPRI guidance was raised to $1.25–1.40B from “at least $1B,” with the peak-revenue estimate raised above $7B and TPIP’s above $6B. Kept out of the Top 5 only on this desk’s Beta ≥1.0 floor (β0.33) — expect a smaller intraday range than a 28% gap implies. Long on ORB. |
| MRNA | Moderna, Inc. | $56.26 | +3.58% | Day 5.16M | β~2.0 (est.) / ATR ~$3.00 | The FDA approved mFLUSIVA (mRNA-1010) on Aug. 5 for all adults 50 and older — the first mRNA-based seasonal influenza vaccine ever cleared and Moderna’s fourth approved US product, arriving exactly on the PDUFA target date after a unanimous 9–0 VRBPAC vote in June. Clearance in the 65+ group came under accelerated approval contingent on a postmarketing study. Q2 revenue of $145M (+2% YoY) exceeded the upper end of guidance, net loss narrowed 5% to $782M, cash costs fell 10% YoY, $6.9B of cash on hand, and FY26 guidance was reaffirmed at up to 10% growth. Also advanced mRNA-1469 (Bundibugyo ebolavirus) into Phase 1 with up to $50M of CEPI funding. Long. |
| NVO | Novo Nordisk A/S | $44.53 | +2.83% | Day 22.28M | β~0.5 (est.) / ATR ~$1.60 | Q2 published Aug. 5: adjusted sales grew 7% to DKK 78.49B on strong GLP-1 and obesity franchise growth and rapid global uptake of the Wegovy pill, and full-year 2026 guidance was raised — yet the stock fell 4–6% as pipeline setbacks and intensifying Eli Lilly competition overshadowed the print. Today’s move is the bounce off that overreaction, and it is the third leg of the day’s healthcare catalyst cluster. Caveat: a ~0.5 Beta and a large-cap ADR structure mean this is a slow, orderly mover — a hold-the-gap trade, not a momentum runner. Long. |
| ORCL | Oracle Corporation | $144.39 | −2.86% | 306K | β2.49 / ATR $7.80 | The one short in the Secondary book, and the cleanest vehicle for the software de-rating that does not carry an already-crushed 15–24% gap. No company-specific print — this is pure cohort sympathy as DDOG, HUBS, APP and FIG all repriced overnight, with NOW (−3.22%), CRWV (−3.10%) and NBIS (−4.14%) moving in lockstep. A 7.60× 5-minute RVOL on a modest 2.86% gap says the selling is institutional rather than retail. The 2.49 Beta and $7.80 ATR give real range for a short on an opening-range failure — more room than the exhausted names have left. |
| AEVA | Aeva Technologies, Inc. | $19.61 | +27.49% | 198K | β3.05 / ATR $1.96 | Largest raw gap on the first scanner pull. Q2 revenue $6.1M vs. $5.5M a year earlier; SICK launched its first Eve-powered industrial sensor and named Aeva its 2026 Supplier of the Year; the company launched an Optical Connectivity business for next-generation AI data centres and signed a joint development agreement with a hyperscaler. Two caveats: only 198K pre-market shares against a 27% gap is thin, and the name dropped off the second scanner pull entirely. Wait for real opening volume before committing, or pass. |
⚡ Screened out and why: DDOG (−15.95%, 1.15M PM vol) and APP (−19.10%, 452K) both improved off their worst levels between scanner pulls — the beat is intact in each, which makes them the two most squeeze-prone shorts in the cohort. CELH (−14.41%, 2.84M) is the day’s only clean operational miss, with the flagship brand down 11.7%, but sits outside today’s book. FISV (−12.00%, 1.53M) fails the Beta ≥1.0 floor at β0.85, as do HUBS (β0.68), FIG (β0.91) and NOW (β0.93). QBTS (−12.15%, 2.62M) clears every stat but is excluded under this desk’s standing rule against shorting quantum names on a gap alone. CHYM (+7.64%, 814K) and MGNI (+10.55%, 182K) are both valid longs that lost their slots to the Top 5 reshuffle.
Themed Movers
The market drew a hard line this week between who sells AI infrastructure and who buys it. NVDA won SpaceX’s stack exclusively for the Starmind orbital-compute programme and added ~$178B of market value. AMD lost its place in that stack and fell 7.0% despite record results. SPCX, which is writing the $15.8B quarterly cheque, fell 13.6% on a 92% revenue beat. SanDisk beat across the board and still fell after hours. Meanwhile the AI-cloud spenders followed overnight: CRWV −3.10%, NBIS −4.14%, IREN −2.28%, APLD −2.41% on a 13.71× 5-minute RVOL.
Three separate, hard, same-week catalysts landing in one sector on a day when tech is being sold. INSM +28.70% on a full-year BRINSUPRI guidance raise from “at least $1B” to $1.25–1.40B and a peak-revenue estimate lifted above $7B. MRNA on the FDA’s Aug. 5 approval of mFLUSIVA — the first mRNA seasonal flu vaccine ever cleared, on its exact PDUFA date after a unanimous advisory vote. NVO bouncing after a 7% adjusted-sales quarter with raised FY26 guidance was sold 4–6% on pipeline and competition worries. OSCR is the group’s outlier at −4.80% on 992K shares.
Eight software names are red pre-market and five are down double digits — HUBS −23.5%, APP −19.1%, DDOG −16.0%, FIG −15.2%, HONA −18.5% — with ORCL −2.9%, NOW −3.2% and ZETA −3.7% dragged along in sympathy. Four of the five biggest decliners beat their quarter. This is cohort-wide multiple compression, which is precisely why it shows up as a −0.57% NQ1! print rather than as an isolated single-stock chart. Watch that several improved off their worst levels between the two scanner pulls — the squeeze risk is real.
Session Playbook
Claims consensus is 203K vs. 197K prior — near 57-year lows either way, so the number itself is unlikely to move much. Unit labor costs at a consensus +2.2% vs. +1.8% prior is the print with genuine inflation signal, and Governor Cook is on record saying she is prepared to raise rates. A hot ULC reading lifts yields, pressures gold and adds another leg to the tech de-rating.
U carries the largest qualifying gap (+16.97%) on the second-heaviest pre-market volume (2.50M) with a 5.99× 5-minute RVOL — highest-conviction long, and the gap widened while volume grew. IONQ gives the widest range (ATR $3.28, β4.99) and OKLO the highest 5-minute RVOL on the scanner at 9.25×. With an all-long book, correlation is the risk: let the 5-minute range complete on each and stagger entries rather than opening everything at 9:30.
10.97M pre-market shares, roughly 4× the next name, and the stock is bid +2.25% into its own supply event. The thesis is that only the first 20% of eligible shares can move, Musk stays locked until mid-2027, and the −13.6% day already paid for it. The trigger is the opening range holding; if it breaks down instead, stand aside — do not average into a genuine unlock flush. Highest-variance name on the board ($11.13 ATR, β5.36). Watch RKLB for sympathy read-through.
ORCL’s modest −2.86% gap on a 7.60× 5-minute RVOL leaves room that DDOG (−15.95%) and APP (−19.10%) no longer have — and both of those improved off their lows between scanner pulls, which is the squeeze warning. On the other side, watch XLV against XLK: a green healthcare open on above-average volume confirms INSM, MRNA and NVO as genuine rotation rather than three isolated reactions.
No confirmed Trump speaking event inside the 9:30 AM–4:00 PM ET window today — he returns from Las Vegas at a time TBD — so that channel is quiet, unlike yesterday’s Red Rock remarks. The live risk is a formal Iran–Oman joint announcement, which would send crude back down and reverse this morning’s energy bounce.
The week’s decisive print, and with a hawkish Fed governor on the record a hot number is the tail risk this tape is not positioned for. Standing desk rule applies regardless: intraday breakouts only, no overnight holds. OKLO also reports tomorrow morning — a second reason to be flat in that name specifically.
Overnight Intelligence
🌏 Asia / Pacific
🌍 Middle East / Macro
The Days Ahead
| Date | Event / Description |
|---|---|
| Thu Aug 6 | TODAY — Jobless Claims + Q2 Productivity & Unit Labor Costs 8:30 AM · SpaceX 911.5M-share / ~$116B lockup expiry · FISV, WBD, COP earnings BMO · ABNB, LYFT, NET earnings AMC A split tape: Dow futures within 271 points of a record against the only red Nasdaq contract of the week, driven by a cohort-wide software de-rating in which four of the five biggest decliners actually beat. No confirmed Trump speaking event inside the session window. |
| Fri Aug 7 | July Nonfarm Payrolls · Oklo (OKLO) Q2 Earnings The week’s decisive print. Labor reports so far have leaned softer — ADP below forecast, Challenger job cuts at a two-year low — but weekly claims sit near 57-year lows and Governor Cook has openly floated a hike. A hot number is the tail risk this tape is not positioned for. |
| Mon Aug 10 | Rocket Lab (RKLB) Q2 Earnings AMC The next real catalyst in the Space/Satellite theme, and it lands after a week in which SPCX set a distinctly negative tone for the sector — both the capex scrutiny and the lockup supply. |
| Ongoing | SpaceX Staggered Lockup Schedule · Figma Lockup Releases Today is the first of multiple SPCX unlock dates, with Musk and select insiders locked until mid-2027 — the supply overhang is a multi-week story, not a one-session event. FIG is separately facing an approaching ~$2.2B share unlock, which is already showing up in its post-beat selling. |
| Wed Aug 26 | NVIDIA (NVDA) Q2 Earnings Now carrying extra weight after Musk named Nvidia SpaceX’s exclusive AI-chip supplier on Tuesday’s call — a single-customer commitment at a scale that will be scrutinised in the guide. |